PM360, a leading trade magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries, has named physIQ as one of the most innovative Companies of 2019.
PhysIQ’s mission is to deliver on the promise of scalable personalized medicine by applying artificial intelligence to data collected from any wearable biosensor and transforming it into personalized insight. The physIQ solution provides clinicians with tools to proactively engage at-risk patients, as well as provide pharmaceutical companies with powerful data-driven support to demonstrate the efficacy of their products.
Using an AI-based approach to personalized physiology analytics, physIQ has been clinically validated, with multiple market-leading 510(k) clearances that include respiration rate, QRS detection, heart rate, heart rate variability, atrial fibrillation detection, and our personalized physiology change detection analytic.
“Previously, physicians and clinical trial sponsors were limited in monitoring ambulatory patients with noisy and very sporadic point-measurement data. PhysIQ enables them to collect high quality continuous data to gain better insights and make better decisions for their patients,” said physIQ’s CEO Gary Conkright. “With physIQ, pharmaceutical companies will now have greater clarity on the impact clinical trials have on patients, allowing for new life saving therapies to reach the market faster. As a result, physicians will have a better chance to care for their patients in their own homes at the lowest possible cost while delivering the highest quality of life.”
PhysIQ was selected as part of PM360’s 8th Annual Innovations Issue published each December. This issue was established to serve as a guide to the year’s most innovative Companies, Startups, Divisions, Products, Services, and Strategies from within the healthcare and life sciences industries. This comprehensive overview of the year’s most innovative achievements in these six categories helps other companies in the industry to find potential partners and offerings that can help them advance healthcare and life sciences.
“For the past eight years, we have worked to help the industry identify the latest and most exciting advancements that facilitate change in the industry, how it operates, or offer new advancements that better serve patients, doctors, payers, and others involved,” says Anna Stashower, CEO/Publisher of PM360. “We hope this guide can serve as an important resource for the industry throughout 2020 as we all work to improve the healthcare experience for everyone involved.”
PM360 received hundreds of submissions from across the healthcare and life sciences industries. The editorial staff of PM360 evaluated each submission and selected their picks for the most innovative, regardless of category. Ultimately, 60 total innovations were featured in the issue. Within the Company category, a total of 12 companies were featured.
All of this year’s selections can be found at: www.pm360online.com/pm360-presents-the-2019-innovators.
About physIQ
PhysIQ is a company dedicated to enabling proactive care delivery models through pinpointIQ™, its highly scalable cloud-based platform for personalized physiology analytics. Our FDA 510(k)-cleared data analytics platform is designed to process multiple vital signs from wearable sensors to create a personalized dynamic baseline for each individual. By mapping vital sign relationships this way, physIQ’s analytics detect subtle deviations that may be a precursor to disease exacerbation or change in health. With applications in both healthcare and clinical trial support, physIQ is transforming continuous physiological data into insight for providers, health systems, payers and pharmaceutical and medical device companies. For more information, please visit www.physIQ.com. Follow us on Twitter and LinkedIn.
About PM360
PM360 is the premier, must-read magazine for marketing decision makers in the pharmaceutical, biotech, medical device, and diagnostics industries. Published monthly, PM360 is the only journal that focuses on delivering the full spectrum of practical information necessary for product managers and pharmaceutical marketing professionals to succeed in the complex and highly regulated healthcare environment.
The journal’s targeted and insightful editorial focuses on issues that directly impact critical decision making, including: Planning and implementation of cutting-edge strategies, trends, the latest technological advances, branding/marketing, advertising/promotion, patient/professional education, sales, market research, PR, and leadership. Additionally, the “360” in the title signifies the span of this critical, how-to info with personal and career insights for an enjoyable and thought-provoking read.
By providing the full circle of enriching content, PM360 is truly an indispensable tool for busy and productive marketing professionals to stay at the top of their game.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191217005511/en/